Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Infection leaves that causes delayed tissue loss during repair

In , pre-existing causes delayed cell loss during repair despite and . Injury should follow faulty divisions and shift with a reversible delay in .

Omega Point 1.2

Stage of verification

  1. Hypothesis published2026-09-21
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionWhole body

Biological function

Epithelial progenitor cells replicate their DNA and divide to regenerate tissue during repair.Epithelial tissue regeneration

Direction

Kind of knowledge gap

The available measurement is only an indirect stand-in for what matters.Proxy gap

A double ring marks the main placement where a group contains several values.

Lens
Replication coupled genomic failure
Goal
Clearance–Resolution Sequence Failure and Damage Amplification Control
Competing hypotheses
2
Published
2026-09-21
Engine version
Omega Point 1.2
As a hypothesis
8 / 10Clarity of mechanism
8 / 10Few extra conditions
9 / 10Completeness of the answer
4 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Rhythm or programme

    The process by which a cell enters the cycle leading to replication and division

    Where this hypothesis actsSurviving with during after infection

    Hypotheses on this target 1
    Cell-cycle entryInhibition. Hypotheses on this target 11Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Rhythm restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition1
    • Activation
    • Function preservation
    • Feedback restoration
    • Rhythm restoration
    • Direct measurement

    What is proposed

    Inhibition

    Reversibly delay to test whether division determines injury timing

    With whatNot stated in the record

    HowUse an experimental, reversible delay; the technique is not stated. Assess recovery after release because preventing also prevents repair

    Possible result

    Expected shift in injury onset matching the delay, with division-associated injury returning unless resolve

    From the recordA reversible experimental delay of cell-cycle entry shifts injury onset by the corresponding interval; releasing the delay restores division-associated injury unless lesions have resolved.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesInterleukin-11. Hypotheses on this target 5Interleukin-11Antibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGenotoxic microbial toxins. Hypotheses on this target 1Genotoxic microbial toxinsGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHeme-associated iron. Hypotheses on this target 1Heme-associated ironHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsExtrachromosomal DNA. Hypotheses on this target 2Extrachromosomal DNAAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesGenomic alterations. Hypotheses on this target 1Genomic alterationsHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p300PCMT1. Hypotheses on this target 2PCMT1TIM-4. Hypotheses on this target 2TIM-412-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIContractile proteins. Hypotheses on this target 1Contractile proteinsDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenasegp130. Hypotheses on this target 1gp130HCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2IL-11 receptor alpha. Hypotheses on this target 1IL-11 receptor alphaInterleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6Talin. Hypotheses on this target 1TalinTLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsT cells. Hypotheses on this target 4T cellsEpithelial cells. Hypotheses on this target 3Epithelial cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueDamaged cells. Hypotheses on this target 2Damaged cellsMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsApoptotic bodies. Hypotheses on this target 1Apoptotic bodiesBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkConnective tissue. Hypotheses on this target 2Connective tissueSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCell-surface macromolecular brush. Hypotheses on this target 1Cell-surface macromolecular brushCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressExtracellular matrix mechanics. Hypotheses on this target 1Extracellular matrix mechanicsHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsMuscle fiber architecture. Hypotheses on this target 1Muscle fiber architectureSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 9EfferocytosisEpithelial barrier repair. Hypotheses on this target 7Epithelial barrier repairLipid peroxidation. Hypotheses on this target 7Lipid peroxidationSensory afferent activity. Hypotheses on this target 7Sensory afferent activityProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 5Calcium phosphate mineral growthInflammatory response. Hypotheses on this target 5Inflammatory responseTissue renewal timing. Hypotheses on this target 5Tissue renewal timingAntigen presentation. Hypotheses on this target 4Antigen presentationAntigen-receptor signaling. Hypotheses on this target 4Antigen-receptor signalingInflammation resolution. Hypotheses on this target 4Inflammation resolutionVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentDNA repair. Hypotheses on this target 2DNA repairEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationMechanical loading. Hypotheses on this target 2Mechanical loadingOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTranscription. Hypotheses on this target 2TranscriptionTranscription–replication conflicts. Hypotheses on this target 2Transcription–replication conflictsTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportUbiquitin-dependent proteasomal degradation. Hypotheses on this target 2Ubiquitin-dependent proteasomal degradationAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCardiovascular feedback regulation. Hypotheses on this target 1Cardiovascular feedback regulationCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle alignment. Hypotheses on this target 1Cell-cycle alignmentCell-cycle restraint coordination. Hypotheses on this target 1Cell-cycle restraint coordinationCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentriole duplication. Hypotheses on this target 1Centriole duplicationCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCortisol inactivation. Hypotheses on this target 1Cortisol inactivationCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHeterotypic cell replacement. Hypotheses on this target 1Heterotypic cell replacementHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLactate-to-glucose recycling. Hypotheses on this target 1Lactate-to-glucose recyclingLipid-dependent receptor signaling. Hypotheses on this target 1Lipid-dependent receptor signalingLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal exocytosis. Hypotheses on this target 1Lysosomal exocytosisLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkNuclear-envelope rupture. Hypotheses on this target 1Nuclear-envelope ruptureNuclear rejuvenation. Hypotheses on this target 1Nuclear rejuvenationNutrient uptake and metabolism. Hypotheses on this target 1Nutrient uptake and metabolismOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismOxygen delivery. Hypotheses on this target 1Oxygen deliveryParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPathogen production. Hypotheses on this target 1Pathogen productionPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPotassium uptake. Hypotheses on this target 1Potassium uptakePreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRepair-initiation signaling. Hypotheses on this target 1Repair-initiation signalingRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSodium reabsorption. Hypotheses on this target 1Sodium reabsorptionSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionCell-cycle entry. Hypotheses on this target 1Cell-cycle entry
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Tissue might keep deteriorating after an infection is controlled because rebuilding exposes damage left behind in its surviving cells. The unexpected move is that repair itself could trigger further loss: damaged cells survive until they try to divide. This is a proposal generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. An initiating infection damages in surviving tissue-rebuilding cells.
  2. The damage is proposed to persist as blood inflammation normalizes and microbes are controlled.
  3. Repair moves damaged cells from survival without division into copying and dividing their genetic material.
  4. Faulty separation during those divisions causes delayed cell loss.
  5. Repeated division-associated losses impair tissue recovery without requiring continued microbes or harmful material outside cells.
A picture for it

A damaged sheet can remain intact on a shelf but tear when it is unfolded for use. The damage happened earlier; handling reveals its consequences later.

Where the picture breaks: Living cells can repair damage, stop dividing, or die through several routes. The picture does not establish that is present or that division causes the proposed losses.

  1. Master questionstep 01 of 04

    Lasting recovery from would require restoring both broad, rapid defenses and defenses targeted to particular threats to healthy young-adult ranges. That recovery must retain protection learned from earlier infections, avoid attacks on the body's own tissues, and keep dormant infections controlled.

    Rests on: The goal itself defines recovery as restored function with these protections preserved, rather than improvement in a single measurement.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Removal of harmful material, the ending of inflammation, and control of damage that generates further damage are identified as a focus.

    Rests on: The master goal requires durable recovery, but does not explain how failure in this sequence prevents it.

    Assumption

    The title takes this sequence to be relevant to durable immune recovery; no accompanying text establishes its role or necessity.

  3. Gap questionstep 03 of 04

    Normal blood measures of inflammation could coexist with worsening function. Selectively suppressing microbes or neutralizing harmful material outside cells is proposed as a way to distinguish hidden infection from tissue damage that sustains itself, before recovery becomes impossible.

    Rests on: The preceding title identifies failures in removal and recovery, but supplies no account of the mismatch between blood measurements and tissue function or of how the two interventions would separate its causes.

    Leap

    The chain does not establish that the proposed interventions distinguish these causes, or define the recovery limits invoked by the question. The supplied sources do not settle those points.

  4. Hypothesisstep 04 of 04

    Infection is proposed to damage , the structures that package genetic material, in surviving , cells that rebuild tissue linings. Later repair makes these cells copy and divide their genetic material, revealing damage through faulty separation and cell loss even after microbes and harmful material outside cells are controlled.S6

    Rests on: The preceding question supplies the possibility of self-sustaining tissue damage. For the initiating premise, S6, a 2006 Science abstract, reports that contact with bacteria carrying a particular gene cluster causes breaks across both strands of deoxyribonucleic acid, or , the molecule carrying genetic instructions, followed by a halt in cell division and eventual death. It does not establish surviving tissue-rebuilding cells with persistent , delayed deaths during repair, or independence from continued infection.

    Supported by literature

What is carried, and what is not. S6 speaks to the starting premise that bacteria can damage genetic material, but its 2006 Science abstract does not establish the proposed delayed repair mechanism. None of the supplied sources establishes the sequence from damage surviving infection control through faulty divisions to continuing tissue loss; the literature support assigned to the hypothesis concerns its starting premise only.S6

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The title takes this sequence to be relevant to durable immune recovery; no accompanying text establishes its role or necessity.
  • Gap question. The chain does not establish that the proposed interventions distinguish these causes, or define the recovery limits invoked by the question. The supplied sources do not settle those points. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • A signal associated with genetic damage could be mistaken for an actual . S8, a 2025 Cell Reports abstract, reports accumulation of a without detectable breaks during an epithelial response to infection; it does not establish the proposed damage persisting after infection control.S8 What closes it: must be established before division and connected to subsequent faulty division and death in the same tracked cells. Marker measurements alone cannot establish the proposed sequence.
  • Fewer deaths while cell division is delayed could be mistaken for restored tissue function, although the delay also prevents repair. A shifted injury onset could also coincide with changes in during the waiting period. What closes it: The design requires recovery assessment after the delay is released. Division, , cell death, and tissue function must be followed together through release to distinguish postponed injury from repaired damage and productive recovery.
  • Failure of treatments to prevent deaths could be credited to an internal mechanism when microbes or damaging activity remain locally active. Failure of collected to transfer injury would not by itself exclude the rival that requires a local spatial arrangement of injury and inhibition. What closes it: The proposed verification of microbial suppression and sustained neutralization must establish control where injury occurs. The spatial rival also requires assessment within intact tissue; a negative fluid-transfer result alone cannot eliminate it.

What would make this wrong. The central mechanism would be contradicted if, after verified microbial suppression and sustained neutralization of harmful material outside cells, new injury consistently preceded faulty divisions or occurred in cells without the proposed pre-existing . Its timing prediction would also fail if a verified reversible delay in division left injury onset unchanged while the remained unresolved.

What it would change. If this mechanism held, controlling infection and harmful material outside cells could leave a separate barrier to recovery: damaged surviving cells that fail when called upon to rebuild tissue. Work toward durable immune restoration would then have to distinguish productive repair from repair attempts that cause further loss. Results in , laboratory-grown three-dimensional tissue models made from donor cells, would still not establish lasting restoration of immune function in older people while preserving learned protection, restraint against self-attack, and control of dormant infections. The supplied material also does not define , the named outcome expected to stabilize.

Sources read · 10

4 literature searches, 6 full texts, 4 abstract-only; 10 source(s) read in full against this question. A bounded search is not evidence of absence.

S1Background

Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa. · Proceedings of the National Academy of Sciences of the United States of America · 2023

“Genes associated with the DNA damage response ( PARP1 , WDR76, and CHEK1 ) were mainly enriched in HS BII cells”

Does not settle: This source does not establish infection-induced chromosome damage, persistence of lesions in surviving progenitors, delayed segregation failure during regeneration, tissue-cell loss, resolution of inflammation or pathogens, or whether organisms and extracellular histone/protease activity are unnecessary.

S2Partly answers it

Responses of gastric epithelial stem cells and their niche to Helicobacter pylori infection. · Annals of translational medicine · 2020

“This interaction with the epithelium can lead to altered cell signaling, DNA damage and aberrant epithelial immunity.”

Does not settle: This source does not establish that chromosome damage persists in surviving epithelial progenitors after infection control, that regeneration causes chromosome-segregation failure and delayed tissue-cell loss, or that viable organisms and extracellular histone/protease activity are unnecessary once lesions exist.

S3Partly answers it

H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer. · Digestive diseases and sciences · 2013

“In this study we showed that oxidative DNA damage of Lgr5-positive epithelial cells in gastric mucosa, determined by the levels of nuclear 8OHdG, was increased as compared to Lgr5-negative epithelial cells in patients with gastric cancer and H. pylori infection but not in gastric cancer patients without H. pylori infection.”

Does not settle: It does not establish chromosome damage, persistence of lesions after pathogen control or inflammation normalization, regeneration-associated mitotic failure or delayed tissue loss, or whether viable organisms and extracellular histone/protease activity are unnecessary.

S4Partly answers it

Molecular Mechanisms of Alveolar Epithelial Stem Cell Senescence and Senescence-Associated Differentiation Disorders in Pulmonary Fibrosis. · Cells · 2022

“Recently it was reported that SARS-Cov-2 viruses cause acute pulmonary virus-induced senescence (VIS), and subsequently fibrosis, illustrating a major mechanism of coronavirus disease 2019 (COVID-19)”

Does not settle: This review does not establish that infection leaves unrepaired chromosome damage in surviving epithelial progenitors, that regeneration causes chromosome-segregation failure and tissue-cell loss, or that these outcomes persist without viable pathogens or extracellular histone/protease activity.

S5Background

Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease. · Molecular cell · 2021

“These effects include dysregulation of histone modification and gene expression profiles, perturbation of DNA synthesis and cell proliferation, and together eventually lead to PARP-dependent cell death.”

Does not settle: This source does not establish that an initiating infection leaves unrepaired chromosome damage in surviving epithelial progenitors, that regeneration causes chromosome segregation failure or delayed tissue loss, or that pathogens and extracellular histone/protease activity are unnecessary after such lesions exist.

S6Partly answers itAbstract only

Escherichia coli induces DNA double-strand breaks in eukaryotic cells. · Science (New York, N.Y.) · 2006

“Contact with E. coli expressing this gene cluster causes DNA double-strand breaks and activation of the DNA damage checkpoint pathway, leading to cell cycle arrest and eventually to cell death.”

Does not settle: This abstract does not establish damage in surviving epithelial progenitors, delayed loss during tissue regeneration, chromosome segregation failure during mitosis, normalization of inflammation or pathogen control, or that persistent organisms and extracellular histone/protease activity are unnecessary.

S7Background

Altered memory CCR6+ Th17-polarised T-cell function and biology in people with HIV under successful antiretroviral therapy and HIV elite controllers. · EBioMedicine · 2024

“increased levels of cleaved PARP and phosphorylated H2AX in STs and ECs confirm higher levels of DNA damage in HIV-infected individuals regardless of ART or natural HIV control.”

Does not settle: It does not establish chromosome damage in surviving epithelial progenitors, delayed tissue loss during regeneration, chromosome segregation failure, or whether such lesions cause repair failure without persistent organisms or extracellular histone/protease activity.

S8Contradicts itAbstract only

Infectious bacteria, but not the microbiota, induce a NOX-ATM-cytokine pathway that controls epithelial turnover. · Cell reports · 2025

“γH2av accumulation occurred without detectable DNA breaks and required both the Ataxia Telangiectasia Mutated (ATM) kinase and the NADPH oxidase enzyme NOX.”

Does not settle: This abstract describes an epithelial response during infection and coordinated ISC-mediated repair, but does not establish unrepaired chromosome damage in surviving progenitors, delayed mitotic segregation failure during regeneration, tissue loss after inflammation/pathogen control, or the claimed independence from persistent organisms or extracellular histone/protease activity.

S9BackgroundAbstract only

The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. · Clinical science (London, England : 1979) · 2017

“At the molecular level, cancer progression is due to increased expression of the viral oncoproteins E6 and E7, which activate the cell cycle, inhibit apoptosis, and allow accumulation of DNA damage.”

Does not settle: This abstract does not establish delayed tissue loss during repair, chromosome segregation failure in surviving epithelial progenitors, lesion persistence after pathogen control, or whether regeneration can be stabilized while preserving productive repair.

S10BackgroundAbstract only

Oxidative DNA damage: mechanisms, mutation, and disease. · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2003

“this review critically addresses the extent to which the in vitro significance of such damage has relevance for the pathogenesis of disease.”

Does not settle: It does not establish infection-induced chromosome damage in epithelial progenitors, delayed regeneration-associated segregation failure or tissue loss, pathogen clearance, extracellular histone/protease independence, or effects on SPV_5.

The gap this hypothesis explains

What is measured here stands in for what matters, and may not track it.

Can suppressing hidden infection versus neutralizing released damage material distinguish why tissue function worsens before recovery becomes impossible?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

When blood inflammation normalizes but function deteriorates, can selective versus distinguish from before either exceeds recovery limits?

What this question is asking

The question concerns worsening tissue function despite blood measurements suggesting that inflammation has returned to normal. It asks whether selectively suppressing disease-causing organisms, compared with neutralizing potentially harmful material released outside injured cells, can distinguish hidden infection from tissue damage that continues without infection. The comparison would need to show whether functional deterioration responds differently to the two interventions, and whether that difference identifies the responsible cause. The question assumes that existing monitoring detects this mismatch but cannot establish its cause, and asks whether the distinction can be made while recovery remains possible. Its broader setting is restoring immune function in people with age-related immune impairment.

What the terms mean
Inflammation and blood inflammation measurements
Inflammation is a biological response associated with infection, injury, and repair. Blood measurements track selected features of that response; the supplied input does not identify the measurements or define what counts as normal.
Tissue function and recovery limits
Tissue function means how well a body tissue performs its role. Recovery limits name the proposed boundary beyond which that performance cannot be restored; no such boundary is specified or validated here.
Occult infection and selective pathogen suppression
means infection that has not been readily detected. Selective means reducing the disease-causing organism with an intervention intended to act specifically on it.
Extracellular injury cargo and neutralization
This means material released outside cells during injury, and interventions intended to prevent its harmful activity. It is a broad class of material, not one substance, and released material can also participate in recovery.
Autonomous tissue damage
Here this means injury that continues without requiring an ongoing infection. The supplied sources do not establish that independence in the situation posed.
Age-related immune impairment
This means reduced or altered performance of the body's defenses associated with aging. The question's broader aim concerns restoring those defenses, but the supplied studies do not establish that outcome.
RL-2 discordance rules and RL-3 functional tests
These are pipeline labels for rules that flag mismatched measurements and tests of biological performance. Their expansions, procedures, and validation are not provided.
Tissue antigen and injury signatures
An antigen is biological material recognizable by the immune system; an injury signature is a pattern of measurements associated with damage. Finding either does not automatically explain whether the detected material or process is sustaining the damage.
Connexin-43 channels and Peptide5
Connexin-43 forms channels in cell membranes. Peptide5 is the channel-blocking intervention associated with protection in the mouse study described by S1.
Interleukin-1 beta
An immune signaling protein blocked in S2. That study's reported healing outcome cautions against assuming that blocking an inflammation-related signal necessarily improves repair.
Extracellular vesicles
Small membrane-enclosed packages released by cells that carry biological material. They are a class of packages with different contents and effects, including the protective effects described in S3 and injury-associated material examined in S4.
Prosaposin and receptor
Prosaposin is the molecule implicated in the protective signaling described in S3. A receptor is a protein that receives a biological signal; the supplied title and quotation spell this study's receptor label differently.
Nucleic acids and Toll-like receptors 3 and 9
Nucleic acids are molecules that carry genetic information and can also stimulate immune responses when released from cells. Toll-like receptors 3 and 9 are immune sensors whose activation S4 reports inhibiting through nucleic-acid capture.
Fluorodeoxyglucose positron emission tomography
An imaging method using a detectable sugar-like tracer to locate areas of biological activity. S5 discusses its limited ability to distinguish infection from cancer and inflammation without infection.
What the question takes for granted
Premise only partly supported
RL-2 rules and RL-3 detect abnormalities; and do not establish the responsible driver.

The pipeline describes monitoring rules and tests of biological performance that flag a mismatch between reassuring blood results and worsening function. It also assumes that finding recognizable biological material or signs of injury in tissue does not identify what keeps the damage going. If this holds, detecting an abnormality and identifying its cause are separate problems, which motivates the proposed comparison.

S5 supports a narrower concern: the imaging method it discusses sometimes poorly distinguishes infection, cancer, and inflammation without infection. It does not establish the performance of the pipeline's monitoring rules, , or tissue measurements. The supplied sources do not establish that these rules detect deterioration during a defined period when recovery remains possible.S5

The same question asked without the part nothing read establishes:

  • When blood inflammation measurements normalize but tissue function worsens, can suppressing infection versus neutralizing released damage material identify the cause?
  • Can responses to infection suppression and released-material neutralization distinguish infection-driven injury from injury that continues independently of infection?
What turns on the answer
  • The responses distinguish the causes Under the question's proposed logic, improvement specifically following infection suppression would support infection as a continuing driver, while improvement specifically following neutralization would support released material as a driver. For this to identify the cause, the responses would need to distinguish those explanations reliably; the supplied sources do not establish that reliability or whether the distinction arrives before recovery is lost.
  • The responses do not distinguish the causes If both interventions help, neither helps, or their effects cannot be attributed specifically to their intended targets, the response pattern would leave the cause unresolved. Improvement alone would then be insufficient to classify the deterioration as hidden infection or independently continuing tissue damage.
  • The distinction arrives too late Even a reliable distinction could fail the timing requirement if it becomes apparent only after function can no longer recover. Identifying the cause would then settle the explanatory question without establishing the early warning capability the pipeline requires.
Why it matters

If hidden infection sustains injury, suppressing the responsible organism could interrupt the process that damages tissue. If material released by injured cells sustains further damage independently, suppressing infection alone could leave that process active. However, released material can also support recovery: S3 reports that blocking one such signal removes inflammation-resolving effects, although its supplied quotation is unverified. Mistaking a protective signal for harmful material could therefore undermine recovery, while mistaking an intervention response for proof of the underlying cause could leave the actual driver unresolved. The supplied sources do not establish how long either mistake could persist before recovery becomes impossible.

What is already established

RL-2 rules and RL-3 detect abnormalities; and do not establish the responsible driver.

What would have to be true

triggers investigation within the , before persistent dysfunction exceeds clinically justified limits.

What is missing

Convert reassuring into experimentally discriminated causes and validate against subsequent functional deterioration.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

The initiating infection leaves in surviving . Blood inflammation then normalizes and are controlled, but forces damaged cells through , producing delayed and tissue-cell loss. Neither persistent nor ongoing / activity is necessary once these exist. The is unrepaired whose consequences become expressed during attempted . Preventing catastrophic while preserving productive repair should stabilize .

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

With verified and sustained , new injury still follows aberrant divisions of cells carrying pre-existing . shows , , or before cell loss. A reversible experimental delay of shifts injury onset by the corresponding interval; releasing the delay restores division-associated injury unless have resolved. collected before those divisions does not transfer the to undamaged cells. , , and their combination fail to prevent the initial delayed deaths, distinguishing this mechanism from both rivals.

Would tell it apart from at least one rival. The prediction specifies observable temporal ordering, a corresponding shift in injury onset, and outcomes of transfer and treatment interventions. No rival prediction was supplied for comparison. A paper already fetched for this hypothesis bears on it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

allow of cell division, , cell death, and tissue function under the proposed . is a , not evidence of successful treatment: recovery must be assessed after release, because simply preventing also prevents repair.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

With verified and sustained , new injury still follows aberrant divisions of cells carrying pre-existing . shows , , or before cell loss. A reversible experimental delay of shifts injury onset by the corresponding interval; releasing the delay restores division-associated injury unless have resolved. collected before those divisions does not transfer the to undamaged cells. , , and their combination fail to prevent the initial delayed deaths, distinguishing this mechanism from both rivals.

  • What would separate them

    Clearing residual bacteria redirects protein-cutting enzymes toward host tissue predicts: In , increases and new tissue injury after , despite falling and unchanged and . prevents this deterioration. Adding purified, readily cleavable during suppression also prevents injury without changing ; a matched does not. must demonstrate reciprocal movement from microbial to . Failure of to injury despite verified competition rejects this hypothesis. , , and matched released distinguish from or killing-induced release.

  • What would separate them

    Self-organized danger and inhibitor signals sustain tissue injury after infection clears predicts: After independently verified , reveals a reproducible that emerges from small . A before intervention must predict how changing spread changes that wavelength. Spatial redistribution of at can abolish persistent injury, whereas the same mean exposure delivered in the original pattern does not. Uniform, well-mixed preparations relax toward recovery under matched . sufficient to remove the prevents pattern reformation; alone does not. Absence of measurable , , or a rejects this specific mechanism rather than being excused as generic .

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteA paper already fetched for this hypothesis bears on it

What it would take to refute it. 6 paper(s) already retrieved for this hypothesis carry its prediction’s terms. Reading them comes before running anything. Already retrieved: Advances and prospects in fungal disease resistance breeding of roses.; Growth under pressure: The pros and cons of polyploidy induced by stress.; Genome-wide analysis of the <i>EIN3/EIL</i> family in rye and functional identification of <i>ScEIL5</i> in stripe rust resistance..

6 papers retrieved around this hypothesis
  • Growth under pressure: The pros and cons of polyploidy induced by stress.PMID 42190013 · full_text · 72,078 characters stored
  • Advances and prospects in fungal disease resistance breeding of roses.PMID 42677284 · full_text · 116,622 characters stored
  • Exploring Taphrina deformans, the Springtime Scourge of Peach.PMID 42324627 · full_text · 101,241 characters stored
  • Genome-wide analysis of the <i>EIN3/EIL</i> family in rye and functional identification of <i>ScEIL5</i> in stripe rust resistance.PMID 41937784 · full_text · 67,715 characters stored
  • The replicative fitness and virulence of potato virus Y evolve differently in pepper lines with different levels of resistance and tolerance.PMID 41626656 · full_text · 78,551 characters stored
  • Overexpression of the EfMYB124 gene from Erianthus fulvus enhances tolerance to low temperature and drought in Arabidopsis thaliana.PMID 42288788 · full_text · 73,744 characters stored

0 citation handles extracted; 1 Europe PMC search run; 8 records examined; 6 sources stored for enrichment, 6 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.